Search hospitals > California > San Diego
Kaiser Permanente-San Diego Mission
Claim this profileSan Diego, California 92108
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
178 reported clinical trials
11 medical researchers
Summary
Kaiser Permanente-San Diego Mission is a medical facility located in San Diego, California. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Kaiser Permanente-San Diego Mission is involved with conducting 178 clinical trials across 349 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Gary L. Buchschacher, Helen H. Moon, and Ashraf R. Aziz.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Robert M. CooperKaiser Permanente Downey Medical Center8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
49 reported clinical trials
95 drugs studied
Gary L. BuchschacherKaiser Permanente-Anaheim8 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
14 reported clinical trials
34 drugs studied
Helen H. MoonKaiser Permanente-Riverside8 years of reported clinical research
Studies Kidney Cancer
Studies Bladder Cancer
13 reported clinical trials
23 drugs studied
Ashraf R. AzizKaiser Permanente-Baldwin Park6 years of reported clinical research
Studies Multiple Myeloma
Studies Lymphoma
11 reported clinical trials
31 drugs studied
Clinical Trials running at Kaiser Permanente-San Diego Mission
Lung Cancer
Testicular cancer
Breast Cancer
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Acute Lymphoblastic Leukemia
Cancer
Testicular Choriocarcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Multiple Therapies
for Stage III Non-Small Cell Lung Cancer
This trial is testing different treatments to see how well they work and how safe they are. It focuses on patients with advanced lung cancer that cannot be removed by surgery and have specific biological markers. The goal is to find out if these treatments can stop the cancer from growing or spreading and improve patients' health.
Recruiting2 awards Phase 317 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-San Diego Mission?
Kaiser Permanente-San Diego Mission is a medical facility located in San Diego, California. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Kaiser Permanente-San Diego Mission is involved with conducting 178 clinical trials across 349 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Gary L. Buchschacher, Helen H. Moon, and Ashraf R. Aziz.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.